BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PharSafer® - Global Clinical and Post Marketing Drug Safety - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PharSafer® - Global Clinical and Post Marketing Drug Safety
X-ORIGINAL-URL:https://pharsafer.com
X-WR-CALDESC:Events for PharSafer® - Global Clinical and Post Marketing Drug Safety
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Athens
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250410
DTEND;VALUE=DATE:20250412
DTSTAMP:20250321T172110Z
CREATED:20250321T165444Z
LAST-MODIFIED:20250321T172110Z
UID:2870-1744243200-1744415999@pharsafer.com
SUMMARY:Europharm International Business Meeting 2025
DESCRIPTION:Europharm International Business Meeting 2025 \nDate: April 10th–11th\, 2025 \nLocation: Athens\, Greece \nPharSafer® is excited to announce our participation in the upcoming Europharm International Business Meeting 2025\, hosted by Europharm SMC. This esteemed annual gathering brings together key decision-makers from the pharmaceutical industry to discuss innovation\, regulatory strategies\, and global healthcare trends.​ \nWhy Engage with PharSafer? \nWith over two decades of global experience\, PharSafer® assists pharmaceutical\, biotech\, and medical device companies in confidently navigating the evolving regulatory landscape. Our core services include:​ \n\nComprehensive Pharmacovigilance: Ensuring patient safety throughout the product lifecycle\, encompassing both clinical and post-marketing phases.​\nRisk Management Planning: Developing and implementing Risk Management Plans (RMPs)\, Risk Evaluation and Mitigation Strategies (REMS)\, and global risk minimisation strategies.​\nRegulatory Strategy & Compliance: Providing guidance across various markets\, including the EU\, UK\, US\, and emerging regions\, to ensure adherence to regulatory requirements.​\nMedical Affairs & Safety Services: Supporting scientific\, medical\, and safety communication needs to maintain the highest standards of medical information.​\nAuditing\, Training & Inspection Readiness: Offering Good Pharmacovigilance Practice (GVP) auditing\, Standard Operating Procedure (SOP) development\, mock inspections\, and team upskilling to ensure compliance and preparedness.​\nInformatics & Systems: Overseeing pharmacovigilance databases\, implementing RAPTAR® automation\, and utilising Individual Case Safety Report (ICSR) processing tools to enhance efficiency.​\n\nExclusive Speaker Session \nWe invite you to attend a presentation by our CEO\, Dr. Graeme Ladds\, titled:​ \n“What’s Stopping You? Turning Global Compliance Hurdles into Market Opportunities — Your 5-Year Plan” \nIn this session\, Dr. Ladds will share practical insights on transforming regulatory and pharmacovigilance challenges into strategic advantages\, positioning your organisation for success in a complex global market.​ \nConnect with PharSafer® in Athens \nOur senior team will be available throughout the event and welcomes the opportunity to discuss your challenges and explore tailored solutions for your global safety and compliance needs.​ \nSchedule a Meeting \nTo ensure a dedicated time for discussion\, please schedule your meeting with us in advance.​ \nWe look forward to connecting with you in Athens for a productive and insightful event! \n​ \nNote: For more information about the event\, please visit: Europharm International Business Meeting 2025.
URL:https://pharsafer.com/event/europharm-international-business-meeting-2025/
LOCATION:Royal Olympic Hotel Athens\, 28 Athanasiou Diakou Street\, Athens\, 117 43\, Greece
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2025/03/Europharm-1.png
ORGANIZER;CN="Europharm SMC":MAILTO:ave@europharmsmc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250422
DTEND;VALUE=DATE:20250425
DTSTAMP:20250321T172032Z
CREATED:20250321T172032Z
LAST-MODIFIED:20250321T172032Z
UID:2875-1745280000-1745539199@pharsafer.com
SUMMARY:World Orphan Drug Congress USA 2025
DESCRIPTION:World Orphan Drug Congress USA 2025 \nDate: April 22nd–24th\, 2025 \nLocation: Boston\, USA \nPharSafer® is delighted to confirm our participation in the World Orphan Drug Congress USA 2025\, one of the foremost global events dedicated to orphan drug development\, rare disease research\, and regulatory innovation.​ \nExclusive Speaker Session \nJoin Dr. Graeme Ladds\, CEO of PharSafer®\, for his keynote presentation: \n“Safety & Compliance Without Borders: The Orphan Drug Safety Regulatory Checklist” \nIn this must-attend session\, Dr. Ladds will share expert guidance on building a compliant global safety strategy for orphan and ultra-orphan drug development — from early clinical trials to long-term post-marketing surveillance. Drawing from decades of regulatory experience\, this talk explores: \n\nNavigating regulatory divergences across the FDA\, EMA\, MHRA\, Health Canada\, and more\nReal-world case studies and practical tools to transform global compliance into a competitive advantage\nStrategies to manage compassionate use\, rare patient populations\, and long-term safety\nHow to leverage automation to ensure efficiency and data integrity\n\nIdeal for: Regulatory affairs professionals\, rare disease developers\, PV leaders\, clinical operations teams\, and biotech innovators looking to expand globally while remaining compliant. \nAttendees will leave with a deeper understanding of global safety challenges — and a clear checklist to enhance compliance readiness across international markets. \n​Connect with PharSafer® in Boston \nOur senior team will be available throughout the event and would welcome the opportunity to discuss your organisation’s challenges and explore tailored solutions across: \n\nClinical & Post-Marketing Pharmacovigilance\nGlobal Regulatory Strategy & Risk Management Planning\nAuditing\, Training & Inspection Readiness\nMedical Affairs & Safety Communication\nSafety Automation with RAPTAR®​\n\nSchedule a Meeting \nTo ensure a dedicated time with our experts\, we encourage you to schedule your meeting with us in advance. \nWe look forward to connecting with you in Boston for an inspiring and impactful event. \nNote: For more information about the event\, please visit: World Orphan Drug Congress 2025.
URL:https://pharsafer.com/event/world-orphan-drug-congress-usa-2025/
LOCATION:Boston Convention & Exhibition Center\, 415 Summer Street\, Boston\, MA\, 02210\, United States
CATEGORIES:Business Meeting
ATTACH;FMTTYPE=image/png:https://pharsafer.com/wp-content/uploads/2025/03/Europharm.png
ORGANIZER;CN="Terrapinn - WODC US":MAILTO:enquiry.usa@terrapinn.com
END:VEVENT
END:VCALENDAR